MEK Inhibitor PD-0325901 in Patients With Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas
Conditions: Plexiform Neurofibroma; Neurofibromatosis Type 1 (NF1) Intervention: Drug: PD-0325901 oral capsule Sponsor: SpringWorks Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials